Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx Cancer
ECOG-ACRIN Cancer Research Group
Barbara Burtness; Yael Flamand; Harry Quon; Gregory S Weinstein; Ranee Mehra; Joaquin J Garcia; Seungwon Kim; Bert W O'Malley; Enver Ozer; Chukwuemeka Ikpeazu; Wayne M Koch; Neil D Gross; R Bryan Bell; Mihir Patel; Miriam N Lango; Luc G Morris; Russell Smith; Daniel Karakla; Jeremy D Richmon; Floyd C Holsinger; Robert L Ferris
ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, MA.